Global Next Generation Sequencing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Cutting edge sequencing is the way toward sequencing DNA strands like the nucleotides in a DNA atom. Cutting edge sequencing is conveyed by huge parallelization. Cutting edge sequencing decreases the necessities for the piece cloning strategy utilized as a part of sequencing of the genomes by Sanger's technique. Because of high exactness, exact outcomes, and minimal effort, and with low example, cutting edge sequencing is favored over the Sanger's technique. It is normally utilized as a part of oncology examines, biomarker disclosure, rural and creature inquire about, customized solution, and others. Likewise, re-sequencing of targets, distinguishing proof of restricting locales of a transcriptional factor, and non-coding RNA articulation profiling are different utilizations of cutting edge sequencing.

Cutting edge sequencing market is driven by mechanical improvement in cutting edge sequencing, increment in the different applications, diminishing the cost of sequencing, increment in quality mapping programs, expanding computerization for pre-sequencing projects, and advancement of customized pharmaceutical which are relied upon to fuel the cutting edge sequencing market. In addition, ascend in R&D exercises by the market players and medication disclosure applications are driving the interest for cutting edge sequencing (NGS) advertise. Be that as it may, absence of talented experts, moral and legitimate issues in the translation, stockpiling and administration of patient information, and high unwavering quality on subsidizing from the legislature may hamper the cutting edge sequencing market over the estimate time frame.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-next-generation-sequencing-market/#ulp-4H8Z4LpNMLEuOnnx

The next generation sequencing market segmented based on the product and service type, technology, application type, and end user

Based on the product and service type, the next-generation sequencing market segmented into the following:
• Pre-sequencing products and services market
o DNA fragmentation, size selection, A-tailing, and end repair
o Library preparation and target enrichment
o Quality control
• Sequencing services market
o Targeted sequencing/gene panels
o RNA-Seq
o De Novo sequencing
o Exome sequencing
o Chip-Seq
o Whole-genome sequencing
o Methyl-Seq
o others
• Next-generationn sequencing, data analysis, storage, and management (Bioinformatics) market
o NGS data analysis software & workbenches
o NGS data analysis services
o NGS storage management and cloud computing solutions

Based on technology, the next-generation sequencing market segmented into the following:
• Ion semiconductor sequencing
• Sequencing by the synthesis (SBS)
• Nanopore sequencing
• Single-molecule real-time (SMRT) sequencing

Based on application, the next-generation sequencing market segmented into the following:
• Drug discovery
• Diagnostics
• Agriculture and animal research
• Biomarker discovery
• Precision medicine
• Other applications

Based on the end-user, the next-generation sequencing market segmented into the following:
• Biotechnology and Pharmaceutical Companies
• Research Centres
• Hospitals & Clinics
• Others

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-next-generation-sequencing-market/#ulp-c654SbFYO64MsOhu

The global next-generation sequencing market is in growing stage, several local and international players are actively involved in the development and marketing of global next-generation sequencing market. Organizations are focusing on the introduction of low-cost sequencing devices in routine medical check-ups. For instance, Grail is focusing on the development of a next generation sequencing technology that allows detection of different types of cancer before the symptoms appear. This test is expected to reach the market by 2019. Furthermore, companies are also engaged in producing genomic data by making it available to research laboratories worldwide. Growing partnerships, collaborations, increasing adoption of NGS among research laboratories and academic institutes, and the launch of services and novel products by market players fuel the growth of global next generation sequencing market over the forecast period. Moreover, increase in inclination of drug developers and scientists towards the next generation sequencing technology for the development of personalized medicine is a key driver for the demand of next generation sequencing platforms for gaining insights into the genetic organization.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-next-generation-sequencing-market/#ulp-14mlyhjMGhVjZqa3


Next-generation sequencing market segmented into following regions Viz. North America, Asia-Pacific, Latin America, Europe, and Middle East and Africa. North America expected to hold a major share, which is attributed to rise in adoption of next generation sequence, development in the healthcare infrastructure, decrease in the cost, and increase in the R&D activities for proteomic and genomic sequence determination. Moreover, most of the end users for clinical and academic use are from the U.S., U.K., and Germany due to presence of universities offering molecular biology course in these regions might bolster the next generation sequencing market. For instance, in June 2015, Illumina has opened its Europe headquarters in the Cambridge to increase its revenue through 10,000 genome project carried out in U.K. Asia-Pacific is expected to grow at the fastest rate in global next generation sequencing market with owing to increasing investment in development in healthcare expenditure, rising medical awareness in regional population, government funding for translational research, and rising partnerships & agreements among market players. In addition, these countries have less-stringent regulations and data requirements as compared to developed nations; companies find regulatory policies in the Asia-Pacific region to be adaptive and business-friendly.

Some of the players in global next-generation sequencing market are Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), Pacific Biosciences (Danaher Corporation) (U.S.), Thermo Fisher Scientific Inc. (U.S.), Qiagen N. V. (Germany), Beijing Genomics Institute (China), PerkinElmer, Inc (U.S.), F. Hoffmann La Roche AG (Switzerland), Genomatix GmbH (Germany), Oxford Nanopore Technologies (U.K.), and Eurofins Scientific (U.S.) to name a few.

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-next-generation-sequencing-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.